{
    "eid": "2-s2.0-84981186727",
    "title": "T-705 as a Potential Therapeutic Agent for Rabies",
    "cover-date": "2016-08-01",
    "subject-areas": [
        {
            "$": "Immunology and Allergy",
            "@code": "2723"
        },
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        }
    ],
    "keywords": [],
    "authors": [
        "Phatthamon Virojanapirom"
    ],
    "citedby-count": 12,
    "ref-count": 4,
    "ref-list": [
        "Human rabies: Neuropathogenesis, diagnosis, and management",
        "Favipiravir (T-705), a novel viral RNA polymerase inhibitor",
        "Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model",
        "Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Thai Red Cross Agency",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}